相似文献
1
Effect of prolactin and bromocriptine on growth of transplanted hormone-dependent mouse mammary tumours.
Br J Cancer. 1977 Jun;35(6):816-21. doi: 10.1038/bjc.1977.123.
2
Sex hormone receptors in mammary tumours of GR mice.
Nature. 1976 Sep 30;263(5576):386-9. doi: 10.1038/263386a0.
3
Inhibition of mammary tumorigenesis in GR mice with 2-bromo-alpha-ergocryptine.
Int J Cancer. 1979 Jul 15;24(1):92-6. doi: 10.1002/ijc.2910240116.
4
Antitumor activity of FCE 21336, a new prolactin lowering drug, on the MXT mouse mammary carcinoma.
Cancer Lett. 1985 Sep 15;28(2):237-41. doi: 10.1016/0304-3835(85)90080-1.
5
The effect of estrone-progesterone treatment on cell proliferation kinetics of hormone-dependent GR mouse mammary tumors.
Cancer Res. 1975 Dec;35(12):3698-704.
6
Hormone-dependent mammary tumors in strain GR/A mice. III. Effectiveness of supplementary hormone treatments in inducing tumorous phase growth.
J Natl Cancer Inst. 1976 Sep;57(3):527-37. doi: 10.1093/jnci/57.3.527.
7
Hormone-dependent mammary tumors in strain GR/A mice. II. Preneoplastic and neoplastic properties.
J Natl Cancer Inst. 1976 Sep;57(3):519-26. doi: 10.1093/jnci/57.3.519.
8
Mammary tumour development in BR6 mice: hormonal stimulation.
Br J Cancer. 1970 Sep;24(3):568-73. doi: 10.1038/bjc.1970.69.
9
Ergolines as potential prolactin and mammary tumor inhibitors.
Lloydia. 1977 Jan-Feb;40(1):90-106.
10
A prolactin-dependent, metastasising rat mammary carcinoma as a model for endocrine-related tumour dormancy.
Br J Cancer. 1991 Sep;64(3):463-8. doi: 10.1038/bjc.1991.332.
本文引用的文献
1
Mammary tumours in hybrid mice; growth and progression of spontaneous tumours.
Br J Cancer. 1949 Sep;3(3):345-75. doi: 10.1038/bjc.1949.40.
2
STRAIN DD, A NEW HIGH MAMMARY TUMOR STRAIN, AND COMPARISON OF DD WITH STRAIN C3H.
J Natl Cancer Inst. 1964 Jan;32:237-51.
3
OBSERVATIONS ON HORMONAL CONTROL OF MAMMARY CANCER. I. ESTROGEN AND MAMMOTROPES.
J Natl Cancer Inst. 1963 Aug;31:233-59.
4
Responsiveness of mouse mammary tumours to pregnancy.
Eur J Cancer (1965). 1965 Jun;1(1):41-50. doi: 10.1016/0014-2964(65)90078-2.
5
Effects of hypothalamic and amygdaloid lesions on development and growth of carcinogen-induced mammary tumors in the female rat.
Cancer Res. 1969 Aug;29(8):1541-9.
6
Biological and morphological characteristics of mammary tumors in GR mice.
J Natl Cancer Inst. 1971 Apr;46(4):885-97.
7
Growth inhibition of rat mammary carcinoma and endocrine changes produced by 2-Br-alpha-ergocryptine, a suppressor of lactation and nidation.
Eur J Cancer (1965). 1970 Oct;6(5):353-6. doi: 10.1016/0014-2964(70)90031-9.
8
Effects of prolactin or growth hormone on growth of carcinogen-induced mammary tumors of adreno-ovariectomized rats.
Int J Cancer. 1970 Nov 15;6(3):488-95. doi: 10.1002/ijc.2910060320.
9
Suppression by ergocornine and iproniazid of carcinogen-induced mammary tumors in rats; effects on serum and pituitary prolactin levels.
Proc Soc Exp Biol Med. 1970 Nov;135(2):469-72. doi: 10.3181/00379727-135-35076.
10
Mammary tumour development in BR6 mice: ovarian influences and 5-hydroxytryptamine.
Br J Cancer. 1970 Sep;24(3):561-7. doi: 10.1038/bjc.1970.68.
Zotero 插件